Related Experiment Video
Updated: Mar 1, 2026

09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
11.2K
Neonatal Hyperthyroidism with Fulminant Liver Failure: A Case Report
Mohammed Hasosah1, Khalid Alsaleem2, Mansour Qurashi1
1Paediatric Consultant, Department of Paediatrics, King Saud Bin Abdulaziz University for Health Sciences, National Guard Hospital, Jeddah, Saudi Arabia.
Journal of Clinical and Diagnostic Research : JCDR
|June 3, 2017
Summary
Neonatal hyperthyroidism, a rare condition linked to maternal Graves' disease, can cause severe liver failure in infants. Early diagnosis and treatment with carbimazole are crucial for recovery and preventing long-term complications.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Hepatology
Background:
- Neonatal hyperthyroidism is a rare condition, often associated with maternal Graves' disease.
- Hepatic manifestations of neonatal hyperthyroidism are exceptionally uncommon.
Observation:
- A neonate presented with low birth weight and hepatosplenomegaly.
- The infant developed irritability, respiratory distress, and fulminant hepatic failure within days of birth.
- Standard investigations ruled out obstructive, infectious, and metabolic causes of liver failure.
Findings:
- Liver dysfunction in the neonate showed significant improvement following the administration of carbimazole, an anti-thyroid medication.
- Conjugated hyperbilirubinemia, liver enzymes, and INR levels gradually normalized over eight weeks.
- The clinical improvement directly correlated with the initiation of anti-thyroid therapy.
Implications:
- This case highlights the importance of considering neonatal hyperthyroidism as a potential cause of cholestasis and liver failure.
- Prompt identification and treatment are vital to prevent irreversible consequences such as developmental delay or death.
- Early diagnosis and management can significantly improve outcomes for affected neonates.

